We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current ANCN market cap is 0. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -8.32M | -8.64M | -9.05M | -8.2M | -4.37M |
| Net Income | -8.08M | -8.27M | -8.75M | -7.97M | -4.08M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -22.9M | -11.71M | -12.37M | -28.53M | -25.46M |
| Net Income | -27.12M | -11.61M | -12.48M | -27.65M | -24.22M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 50.22M | 43.06M | 35.01M | 28.85M | 23.42M |
| Total Liabilities | 5.6M | 6.84M | 7.06M | 6.86M | 5.38M |
| Total Equity | 44.62M | 36.22M | 27.95M | 21.99M | 18.04M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 19.76M | 6.18M | 64.35M | 43.06M | 22.15M |
| Total Liabilities | 4.85M | 2.6M | 2.89M | 6.84M | 5.15M |
| Total Equity | 14.91M | 3.58M | 61.47M | 36.22M | 17M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -14.67M | -20.37M | -7.19M | -14.67M | -19.89M |
| Investing | 10.18M | 19.53M | 14.43M | 10.16M | 14.16M |
| Financing | 61k | -808k | N/A | 1.37M | 1.37M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -16.46M | -12.71M | -12.37M | -20.37M | -23.61M |
| Investing | -95k | 102k | -45.19M | 19.53M | 15.88M |
| Financing | 26.62M | 297k | 61.07M | -808k | 3.5M |
| Market Cap | 0 |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 0 |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.05 (0.97%) |
| Company Name | Anchiano Therapeutics Ltd |
| Address |
kiryat atidim, building 7 tel aviv, center 6158002 |
| Website | https://www.chemomab.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
